For Institute program-specific acronyms, go to NIAID Profile and Fact Book.
Law from 1996 that sets privacy standards to protect patients' medical records and other health information provided to health plans, doctors, hospitals, and other health care providers. Developed by HHS, HIPAA gives patients access to medical records and improves their control over the use and disclosure of personal health information.
Go to HIPAA.
Law that provides legislative basis for guidelines for the care and treatment of research animals and oversight by institutional animal care and use committees.
Go to Health Research Extension Act of 1985 and NIAID's Animals in Research portal.
Department of Health and Human Services codification of uniform acquisition policies and procedures, which implements and supplements the Federal Acquisition Regulation.
Go to HHSAR.
Area of research NIAID identifies as important to public health or a scientific need or opportunity. NIAID may issue an initiative to solicit grant applications or contract proposals from the extramural research community.
Go to these NIAID resources:
Information that NIH or OMB determines could have an impact of more than $500 million in one year on the public or private sector; is novel, controversial, or precedent-setting; or has significant interagency interest.
See influential scientific information and OMB Information Quality Bulletin for Peer Review.
Go to Final Information Quality Bulletin for Peer Review in the Federal Register.
NIAID term for an infectious agent or toxin that may warrant biosafety level 3 biocontainment or higher according to either CDC's Biosafety in Microbiological and Biomedical Laboratories manual, an institutional biosafety committee, or a designated institutional biosafety official.
If there is a conflict, the highest level applies. Also see select agent.
Go to these resources:
Human subjects term indicating a person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race.
NIH policy requires this minority group to be included in clinical research barring a compelling rationale not to do so. See Planned Enrollment Report and Cumulative Inclusion Enrollment Report.
Term defined by NIH policy as a cell that is derived from the inner cell mass of a blastocyst-stage human embryo, is capable of dividing without differentiating for a prolonged period in culture, and is known to develop into cells and tissues of the three primary germ layers. Also see stem cell.
Go to NIH's Stem Cell Information portal.
Legally defined term for living persons about whom an investigator obtains specimens or data through direct interaction or intervention or through identifiable, private information.
Regulations include but are not limited to human organs, tissues, body fluids, and recorded information. Term is defined differently by laws applying to FDA. See subject.
Go to these resources:
Number a scientific review group places on a summary statement during initial peer review reflecting the application of human subjects regulations to a project as well as the inclusion of women, children, and racial and ethnic populations.
Some codes indicate a human subjects concern that would result in a bar to award.
Human subjects term indicating actual or potential unacceptable risk or inadequate protection against risk to human subjects. See human subjects code and bar to award.
Go to NIAID's Human Subjects SOPs on NIAID Human Subjects Resources portal.
Last Updated September 30, 2014
Last Reviewed May 18, 2012